Calcitriol, parathyroid hormone, and accumulation of aluminum in bone in dogs with renal failure.

doi:10.1172/JCI112881

J Clin Invest. 1987 March; 79(3): 754–761.

doi: 10.1172/JCI112881.

PMCID: PMC424190

Calcitriol, parathyroid hormone, and accumulation of aluminum in bone in dogs with renal failure.

H H Malluche, M C Faugere, R M Friedler, C Matthews, and P Fanti

This article has been cited by other articles in PMC.

Abstract

Accumulation of aluminum in bone is a frequent finding in patients requiring chronic dialysis and is associated with considerable morbidity and/or mortality. Until now, evidence seemed to point to relatively low circulating levels of parathyroid hormone as a contributing factor, but because levels of parathyroid hormone and calcitriol are interrelated, calcitriol might be also involved. In this study we employed an animal model to evaluate the single and combined effects of parathyroid hormone and calcitriol on bone aluminum accumulation. The results show significantly less aluminum accumulation in calcitriol-replete dogs independent of the presence or absence of parathyroid hormone. These results indicate that low levels of calcitriol may play a role in the development of aluminum related bone disease. Further studies are needed to demonstrate whether administration of calcitriol in patients with renal insufficiency will prevent development of aluminum-related bone disease.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.5M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Images in this article

Image
on p.758

Click on the image to see a larger version.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Cournot-Witmer, G; Zingraff, J; Plachot, JJ; Escaig, F; Lefèvre, R; Boumati, P; Bourdeau, A; Garabédian, M; Galle, P; Bourdon, R; Drüeke, T; Balsan, S. Aluminum localization in bone from hemodialyzed patients: relationship to matrix mineralization. Kidney Int. 1981 Sep;20(3):375–378. [PubMed]
Ott, SM; Maloney, NA; Coburn, JW; Alfrey, AC; Sherrard, DJ. The prevalence of bone aluminum deposition in renal osteodystrophy and its relation to the response to calcitriol therapy. N Engl J Med. 1982 Sep 16;307(12):709–713. [PubMed]
Hodsman, AB; Sherrard, DJ; Alfrey, AC; Ott, S; Brickman, AS; Miller, NL; Maloney, NA; Coburn, JW. Bone aluminum and histomorphometric features of renal osteodystrophy. J Clin Endocrinol Metab. 1982 Mar;54(3):539–546. [PubMed]
Smith, AJ; Faugère, MC; Abreo, K; Fanti, P; Julian, B; Malluche, HH. Aluminum-related bone disease in mild and advanced renal failure: evidence for high prevalence and morbidity and studies on etiology and diagnosis. Am J Nephrol. 1986;6(4):275–283. [PubMed]
Faugere, MC; Malluche, HH. Stainable aluminum and not aluminum content reflects bone histology in dialyzed patients. Kidney Int. 1986 Nov;30(5):717–722. [PubMed]
Quarles, LD; Dennis, VW; Gitelman, HJ; Harrelson, JM; Drezner, MK. Aluminum deposition at the osteoid-bone interface. An epiphenomenon of the osteomalacic state in vitamin D-deficient dogs. J Clin Invest. 1985 May;75(5):1441–1447. [PubMed]
Hodsman, AB; Anderson, C; Leung, FY. Accelerated accumulation of aluminum by osteoid matrix in vitamin D deficiency. An animal model of aluminum toxicity. Miner Electrolyte Metab. 1984;10(5):309–315. [PubMed]
Malluche, HH; Faugere, MC. Aluminum: toxin or innocent bystander in renal osteodystrophy. Am J Kidney Dis. 1985 Nov;6(5):336–341. [PubMed]
Alfrey, AC; Sedman, A; Chan, YL. The compartmentalization and metabolism of aluminum in uremic rats. J Lab Clin Med. 1985 Feb;105(2):227–233. [PubMed]
Fanti, P; Smith, AJ; Price, PA; Reitz, RE; Malluche, HH. Effects of parathyroidectomy on circulating levels of 1 alpha,25-dihydroxyvitamin D and bone Gla protein in dialyzed patients. J Clin Endocrinol Metab. 1986 May;62(5):869–873. [PubMed]
Malluche, HH; Matthews, C; Faugere, MC; Fanti, P; Endres, DB; Friedler, RM. 1,25-Dihydroxyvitamin D maintains bone cell activity, and parathyroid hormone modulates bone cell number in dogs. Endocrinology. 1986 Sep;119(3):1298–1304. [PubMed]
PLATT, R; ROSCOE, MH; SMITH, FW. Experimental renal failure. Clin Sci (Lond). 1952 Aug;11(3):217–231. [PubMed]
Friedler, RM; Kurokawa, K; Coburn, JW; Massry, SG. Renal action of cholera toxin: I. Effects on urinary excretion of electrolytes and cyclic AMP. Kidney Int. 1975 Feb;7(2):77–85. [PubMed]
Hightower, D; Kyzar, JR; Chester, DK; Wright, EM. Replacement therapy for induced hypothyroidism in dogs. J Am Vet Med Assoc. 1973 Oct 15;163(8):979–980. [PubMed]
Obie, JF; Cooper, CW. Loss of calcemic effects of calcitonin and parathyroid hormone infused continuously into rats using the Alzet osmotic minipump. J Pharmacol Exp Ther. 1979 Jun;209(3):422–428. [PubMed]
Trechsel, U; Eisman, JA; Fischer, JA; Bonjour, JP; Fleisch, H. Calcium-dependent, parathyroid hormone-independent regulation of 1,25-dihydroxyvitamin D. Am J Physiol. 1980 Aug;239(2):E119–E124. [PubMed]
Hardt, AB; Jee, WS. Trabecular bone structural variation in biopsy sites of the beagle ilium. Calcif Tissue Int. 1982 Jul;34(4):391–395. [PubMed]
Reinhardt, TA; Horst, RL; Orf, JW; Hollis, BW. A microassay for 1,25-dihydroxyvitamin D not requiring high performance liquid chromatography: application to clinical studies. J Clin Endocrinol Metab. 1984 Jan;58(1):91–98. [PubMed]
LeGendre, GR; Alfrey, AC. Measuring picogram amounts of aluminum in biological tissue by flameless atomic absorption analysis of a chelate. Clin Chem. 1976 Jan;22(1):53–56. [PubMed]
Freundlich, M; Zilleruelo, G; Abitbol, C; Strauss, J; Faugere, MC; Malluche, HH. Infant formula as a cause of aluminium toxicity in neonatal uraemia. Lancet. 1985 Sep 7;2(8454):527–529. [PubMed]
Malluche, HH; Meyer, W; Sherman, D; Massry, SG. Quantitative bone histology in 84 normal American subjects. Micromorphometric analysis and evaluation of variance in iliac bone. Calcif Tissue Int. 1982 Sep;34(5):449–455. [PubMed]
Malluche, HH; Sherman, D; Meyer, W; Massry, SG. A new semiautomatic method for quantitative static and dynamic bone histology. Calcif Tissue Int. 1982 Sep;34(5):439–448. [PubMed]
Ellis, HA; McCarthy, JH; Herrington, J. Bone aluminium in haemodialysed patients and in rats injected with aluminium chloride: relationship to impaired bone mineralisation. J Clin Pathol. 1979 Aug;32(8):832–844. [PubMed]
Goodman, WG; Henry, DA; Horst, R; Nudelman, RK; Alfrey, AC; Coburn, JW. Parenteral aluminum administration in the dog: II. Induction of osteomalacia and effect on vitamin D metabolism. Kidney Int. 1984 Feb;25(2):370–375. [PubMed]
Chan, YL; Alfrey, AC; Posen, S; Lissner, D; Hills, E; Dunstan, CR; Evans, RA. Effect of aluminum on normal and uremic rats: tissue distribution, vitamin D metabolites, and quantitative bone histology. Calcif Tissue Int. 1983 May;35(3):344–351. [PubMed]
Andress, DL; Ott, SM; Maloney, NA; Sherrard, DJ. Effect of parathyroidectomy on bone aluminum accumulation in chronic renal failure. N Engl J Med. 1985 Feb 21;312(8):468–473. [PubMed]
Hirschberg, R; von Herrath, D; Voss, R; Bossaller, W; Mauelshagen, U; Pauls, A; Schaefer, K. Organ distribution of aluminium in uremic rats: influence of parathyroid hormone and 1,25-dihydroxyvitamin D3. Miner Electrolyte Metab. 1985;11(2):106–110. [PubMed]